Raymond Cornelison, MD
Dermatology · Chickasha, OKNPI 1003884339
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,577 of the $3,826 with a category attached, or 67.4%. 14 manufacturers reported payments, led by Pfizer at 35.2% of the total. Reporting peaked in 2023 at $1,540 and has fallen 84.5% since, to $238 in 2025. That places this record below the midpoint for dermatology clinicians in OK, where the typical reported total is $4,319.
Across 31 payments — averaging $123.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1K
- Promius Pharma LLC$500
- UCB, Inc.$493
- Arcutis Biotherapeutics, Inc.$369
- AbbVie$236
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$234
- plus $647 from 8 others
Across 142 payments — averaging $3678.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$190K
- AbbVie$74K
- Incyte Corporation$72K
- E.r. Squibb & Sons, L.L.C.$65K
- Sanofi Pasteur Inc.$64K
- Amgen$26K
- plus $32K from 4 others
What the payments were for
- Speaking & faculty fees$50013%
- Travel & lodging$74920%
- Food & beverage$2,57767%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 6 | $1,346 |
| Promius Pharma LLC | 1 | $500 |
| UCB, Inc. | 5 | $493 |
| Arcutis Biotherapeutics, Inc. | 4 | $369 |
| AbbVie | 2 | $236 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $234 |
| E.r. Squibb & Sons, L.L.C. | 2 | $118 |
| Mayne Pharma Commercial LLC | 1 | $113 |
| Boehringer Ingelheim | 1 | $95 |
| Incyte Corporation | 1 | $93 |
| Amarin Pharma, Inc. | 1 | $76 |
| Lilly USA, LLC | 3 | $69 |
| Scpharmaceuticals Inc. | 1 | $67 |
| Merck | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,826 in reported general payments places this provider in the 45th percentile of 114 dermatology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 38 | $2,552 |
| Desonide | 24 | $1,786 |
| Betamethasone Dipropionate | 20 | $1,083 |
| Minocycline Hcl | 30 | $536 |
| Triamcinolone Acetonide | 61 | $504 |
| Cefdinir | 15 | $406 |
| Betamethasone Valerate | 14 | $400 |
| Doxycycline Hyclate | 12 | $369 |
| Hydrocortisone | 23 | $107 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Chickasha
- Thomas HallStillwater$633K
- George MonksTulsa$530K
- Yaohan LamOklahoma City$88K
- Kimberly JerdanOklahoma City$59K
- Mark DawkinsOklahoma City$56K
- Jeff AlexanderTulsa$41K
- Johnathan LedetTulsa$37K
- John AshleyTulsa$24K
- Thomas UriceNorman$23K
- Alison FischerTulsa$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.